Market Place
Sourcing Support
All News #Library
Rare Diseases
Janssen Presents Efficacy and Subgroup Analyses from MAIA Study of DARZALEXÂ
12 Dec 2022 //
GLOBENEWSWIRE
Idorsia sheds surplus DMD therapy to Santhera
21 Nov 2018 //
FIERCE BIOTECH
FDA Approves Imbruvica Plus Rituximab for Rare Blood Cancer
27 Aug 2018 //
R&DMAG
Azafaros to develop new treatments for rare metabolic disorders
23 Jul 2018 //
BIOSPECTRUM
J&J Unit to Sell Sylvant Rights to U.K. Drugmaker Eusa Pharma
18 Jul 2018 //
BLOOMBERG
Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ
23 Jan 2018 //
PMLIVE
Shire offers £12bn-plus for Actelion
08 Jun 2015 //
PHARMA TIMES
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.